* MEDNAX Inc MD.N MD is expected to show a rise in
quarterly
revenue when it reports results on April 28.
* The Sunrise Florida-based company is expected to report
a
5.8% increase in revenue to $472.464 million from $446.75
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for MEDNAX Inc is for
earnings of 27 cents per share. For the same quarter last year,
the company reported earnings of 24 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 7
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MEDNAX Inc
is
$27, above its last closing price of $23.43.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.44 0.44 0.52 Beat 19.2
Sep. 30 2021 0.42 0.42 0.46 Beat 10.6
Jun. 30 2021 0.32 0.32 0.41 Beat 26.4
Mar. 31 2021 0.11 0.13 0.24 Beat 80.9
Dec. 0.36 0.36 0.25 Missed -29.8
31 2020
Sep. 30 2020 0.39 0.40 0.37 Missed -8.2
Jun. 30 2020 0.07 0.09 0.32 Beat 258.7
Mar. 31 2020 0.54 0.54 0.32 Missed -40.8
This summary was machine generated April 26 at 15:24 GMT. All
figures in US dollars unless otherwise stated